Hexarelin is a synthetic hexapeptide GH secretagogue distinguished by its dual activity: potent GH release through ghrelin receptor activation, plus direct cardioprotective effects via CD36 receptor binding on cardiac tissue.
Research Applications
GH axis research (strongest GHRP), cardiac protection studies, post-ischemic cardiac recovery, and CD36 receptor signaling research.
Dosage Information (Research Use)
Research doses: 100-200 mcg subcutaneously, 1-2 times daily. Cycling recommended due to desensitization potential. Research use only.
Reconstitution & Handling
Standard BAC water reconstitution.
Half-Life & Pharmacokinetics
Approximately 70 minutes.
Reported Observations in Literature
Elevates cortisol and prolactin more than Ipamorelin. Increased hunger (ghrelin mimetic effect). Desensitization with prolonged continuous use.
Key Research References
- Bisi G, et al. “Acute cardiovascular and hormonal effects of GH and hexarelin, a synthetic GH-releasing peptide, in humans.” J Endocrinol Invest. 1999